MYAPP4SEP, an application developed with support from the Dr. Daniël de Coninck fund, managed by the King Baudouin Foundation, is transforming the daily lives of people with multiple sclerosis (MS). Designed in close collaboration with patients and caregivers, it offers essential tools to help manage the disease and enhance communication with healthcare professionals.

Multiple sclerosis is a complex condition that affects each patient differently, causing symptoms that can significantly impact daily life. While specialized healthcare teams, such as those at the CHU de Liège, provide personalized care, logistical constraints can sometimes impede access to these vital services. MYAPP4SEP aims to bridge this gap by fostering dialogue between patients and caregivers and offering a suite of customizable features.

The application allows users to organize appointments, take written and audio notes, and track symptoms through pre-consultation checklists and questionnaires. It also provides comprehensive information sheets on the disease, treatments, and their side effects, along with links to additional resources. A community sharing section is included, though designed with privacy in mind.

Incorporating eight care technology principles standardized by the King Baudouin Foundation, the founders consider the principles for improvements and ensure the tool’s value and relevance within the broader social context. Currently, the application has already garnered 338 users, indicating a significant community interest.

We have just completed the assessment of this tool on the basis of the eight care technology principles ,” explains Gaël Delrue, a neuropsychologist at the Liège University Hospital. These principles, established by the Dr. Daniël de Coninck fund, aim to guarantee that technological innovations really serve patients and society.

Launched in the summer of 2023, MYAPP4SEP is continually evolving. User feedback has identified areas for improvement. Some points could not be developed for lack of resources, while other aspects, such as participatory governance, had not been considered initially, notes Delrue, emphasizing the need for continuous development and user involvement.

The developer mentions adjustments are planned to enhance transparency regarding data usage and anonymization, ensuring compliance with the General Data Protection Regulation (GDPR). Additionally, the potential risks of relying on technology and the ethical considerations of data privacy remain hot topics in health technology discourse. Informed consent and data sovereignty are critical in maintaining trust and engagement among users, a point emphasized during the FDA’s recent `mHealth Innovation Challenge.` This indicates the application’s commitment to user-centric development, reflecting broader industry trends and regulatory standards, particularly in the realm of digital health.

While MYAPP4SEP has been successful in Europe, it raises an essential question in the United States: what would it take for similar tools to gain traction domestically? A study by the National Multiple Sclerosis Society highlights the importance of patient engagement and accessible tools in improving quality of life for MS patients. Tools like MYAPP4SEP fill a gap by offering a centralized platform for managing complex health information, promoting self-management, and fostering a sense of community among patients.

However, the adoption of digital health tools, particularly for chronic conditions like MS, faces challenges. This includes barriers to digital literacy, disparities in access to technology, and the need for robust support systems. For example, rural patients may face additional hurdles in adopting such tools, echoes of which were seen during the rapid expansion of telehealth services during the COVID-19 pandemic. MYAPPS4SEP could serve as a valuable model for addressing these challenges, especially highlighting the benefits of collaborative development with end-users (healthcare providers, tech developers and future users) from the outset.

Open-source, MYAPPS4SEP has the potential for an expanded field of action. MyApp4SEP could be presented to the Belgian National League for multiple sclerosis in 2025, with the intention to make it available to other patients in Belgium by adapting it to their needs, concludes Gaël Delrue, neuropsychologist, emphasizes the broader applicability of this tool, suggesting that similar localized adaptation can aid in its acceptance and functionality within other regions.

In conclusion, the development and continuous improvement of MYAPP4SEP are testament to the power of collaboration and innovation in healthcare. By prioritizing user needs and engagement, the application offers a model for future digital health tools. As the reduction in mortality rate inspires hope for similar efforts in digital health care moving forward, it is a beacon of progress in managing complex diseases like MS, supporting both patients and caregivers alike.